Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa

This study has been completed.
Sponsor:
Information provided by:
International AIDS Vaccine Initiative
ClinicalTrials.gov Identifier:
NCT00931346
First received: June 29, 2009
Last updated: August 24, 2011
Last verified: August 2011